Effects of yeast probiotic formulation on viability, revival and protection against infection with Salmonella enterica ssp. enterica serovar Typhimurium in mice

Letters in Applied Microbiology

Volumn 49, Issue 6, 2009, Pages 738-744

  Martins, F S ^a   Veloso, L C ^a   Arantes, R M E ^a   Nicoli, J R ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Probiotic; Saccharomyces boulardii; Saccharomyces cerevisiae; Salmonella enterica serovar Typhimurium

Indexed keywords

DIGESTIVE SYSTEM; YEAST;

AQUEOUS SUSPENSIONS; DIGESTIVE TRACT; HEPATIC TISSUE; IN-VIVO; PROBIOTIC; PROBIOTIC PRODUCTS; PROBIOTICS; PROTECTIVE CAPACITY; PROTECTIVE PROPERTIES; SACCHAROMYCES; SACCHAROMYCES BOULARDII; SACCHAROMYCES CEREVISIAE; SALMONELLA ENTERICA; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM; SEROVAR; SURVIVAL RATE; VIABLE CELLS;

SUSPENSIONS (FLUIDS);

PROBIOTIC AGENT;

BACTERIAL DISEASE; DIGESTIVE SYSTEM; HISTOPATHOLOGY; PROBIOTICS; RODENT; SURVIVAL; VIABILITY; YEAST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFECT; DRUG FORMULATION; HISTOPATHOLOGY; INTESTINE; LIVER; MOUSE; NONHUMAN; SACCHAROMYCES BOULARDII; SACCHAROMYCES CEREVISIAE; SALMONELLA ENTERICA; SALMONELLA TYPHIMURIUM; SALMONELLA VIRCHOW; SURVIVAL RATE; TYPHOID FEVER; YEAST;

MUS; SACCHAROMYCES BOULARDII; SACCHAROMYCES CEREVISIAE; SALMONELLA ENTERICA; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHIMURIUM;

EID: 70449469829     PISSN: 02668254     EISSN: 1472765X     Source Type: Journal    
DOI: 10.1111/j.1472-765X.2009.02732.x     Document Type: Article

References (20)

1. Berg, R.D. (1996) The indigenous gastrointestinal microflora. Trends Microbiol 4, 430 435.
2. Czerucka, D. Rampal, P. (2002) Experimental effects of Saccharomyces boulardii on diarrheal pathogens. Microbes Infect 4, 733 739.
3. Czerucka, D., Piche, T. Rampal, P. (2007) Review article: yeast as probiotics -Saccharomyces boulardii. Aliment Pharmacol Ther 26, 767 778.
4. Diniz, C.G., Arantes, R.M., Cara, D.C., Lima, F.L., Nicoli, J.R., Carvalho, M.A.R. Farias, L.M. (2003) Enhanced pathogenicity of susceptible strains of the Bacteroides fragilis group subjected to low doses of metronidazole. Microbes Infect, 5, 19 26.
5. Ewaschuk, J.B., Diaz, H., Meddings, L., Diederichs, B., Dmytrash, A., Backer, J., Looijer-van Langen, M. Madsen, K.L. (2008) Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function. Am J Physiol Gastrointest Liver Physiol 295, 1025 1034.
6. Fietto, J.L.R., Araújo, R.S., Valadão, F.N., Fietto, L.G., Brandão, R.L., Neves, M.J., Gomes, C.O., Nicoli, J.R. et al. (2004) Molecular and physiological comparisons between Saccharomyces cerevisiae and Saccharomyces boulardii. Can J Microbiol 50, 615 621.
7. He, F., Morita, H., Kubota, A., Ouwehand, A.C., Hosoda, M., Hiramatsu, M. Kurisaki, J. (2005) Effect of orally administered non-viable Lactobacillus cells on murine humoral immune responses. Microbiol Immunol 49, 993 997.
8. Jijon, H., Backer, J., Diaz, H., Yeung, H., Thiel, D., McKaigney, C., De Simone, C. Madsen, K. (2004) DNA from probiotic bacteria modulates murine and human epithelial and immune function. Gastroenterology 126, 1358 1373.
9. Martins, F.S., Neves, M.J., Rosa, C.A., Nardi, R.M.D. Nicoli, J.R. (2005) Comparação de seis produtos probióticos contendo Saccharomyces boulardii. Rev Bras Med 62, 151 155.
10. Martins, F.S., Rosa, C.A., Nicoli, J.R., Machado, D.C.C., Penna, F.J. Neves, M.J. (2006) Efeito do método de conservação na viabilidade, reativação, colonização intestinal e efeito imunomodulador de dois produtos probióticos à base de leveduras. Rev Bras Med 63, 36 41.
11. Martins, F.S., Rodrigues, A.C.P., Tiago, F.C.P., Penna, F.J., Rosa, C.A., Arantes, R.M.E., Nardi, R.M.D., Neves, M.J. et al. (2007) Saccharomyces cerevisiae strain 905 reduces the translocation of Salmonella enterica serotype Typhimurium and stimulates the immune system in gnotobiotic and conventional mice. J Med Microbiol 56, 352 359.
12. Morgan, C.A., Herman, N., White, P.A. Vesey, G. (2006) Preservation of micro-organisms by drying: a review. J Microbiol Meth 66, 183 193.
13. National Research Council (1996) Guide for the Care and Use of Laboratory Animals. Washington, DC : National Academy Press.
14. Ouwehand, A.C., Tölkkö, S., Kulmala, J., Salminen, S. Salminen, E. (2000) Adhesion of inactivated probiotic strains to intestinal mucus. Lett Appl Microbiol 31, 82 86.
15. Poirier, I., Marechal, P.A., Richard, S. Gervias, P. (1999) Saccharomyces cerevisiae viability is strongly dependent on rehydration kinetics and the temperature of dried cells. J Appl Microbiol 86, 87 92.
16. Read, N.W., Al-Janabi, M.N., Holgate, A.M., Barber, D.C. Edwards, C.A. (1986) Simultaneous measurement of gastric emptying, small bowel residence and colonic filling of a solid meal by the use of the gamma camera. Gut 27, 300 308.
17. Sougioultzis, S., Simeonidis, S., Bhaskar, K.R., Chen, X., Anton, P.M., Keates, S., Pothoulakis, C. Kelly, C.P. (2006) Saccharomyces boulardii produces a soluble anti-inflammatory factor that inhibits NF-kappaB-mediated IL-8 gene expression. Biochem Biophys Res Commun 343, 69 76.
18. WHO/FAO. Joint World Health Organization/Food and Agricultural Organization Working Group (2002) Guidelines for the Evaluation of Probiotics in Food, London, Ontario, Canada : WHO/FAO.
19. WHO/FAO/OIE. World Health Organization/Food and Agricultural Organization Background document for the Joint WHO/FAO/OIE expert 2003). Workshop on Non-Human Antimicrobials Usage and Antimicrobials Resistance Scientific Assessment. Geneva, Switzerland : WHO/FAO/OIE.
20. Zaslavzky, C., da Silveira, T.R. Maguilnik, I. (1998) Total and segmental colonic transit time with radio-opaque markers in adolescents with functional constipation. J Pediatr Gastroenterol Nutr 27, 138 142.